In Pursuit of Universal Health Care: Time to Take Public-Private Partnership to the Next Level
Countries already moving toward public-private partnerships
Nigeria, for one, is being very proactive in this regard. Under the leadership of its federal Ministry of Health, the government has already started mobilizing private sector providers as partners in strengthening the delivery of reproductive, maternal, newborn, child and adolescent health and nutrition services (RMNCAH+N), beginning with five states in the country’s fragile northeast region. The aim is to expand service delivery at the community level under a financing arrangement that makes payment contingent upon performance. Cameroon and the Democratic Republic of Congo have also started using performance-based financing contracts with both for-profit and not-for-profit private-sector providers to help fill gaps in RMNCAH-N services.
The Global Financing Facility, launched to support the UN’s Every Woman Every Child initiative, offers a useful framework for these PPPs, and an effective vehicle for leveraging outside support for country-led SDG-related initiatives. It will be important to monitor and evaluate the impact of all of these activities and continue to refine the approach going forward.
In India, one of the focus countries for Merck for Mothers’ own investments, the Federation of Obstetric and Gynaecological Societies of India (FOGSI) is working to scale up a new quality certification program for private maternity care providers, structured as a state-level PPP. Participating providers who demonstrate compliance with quality standards are recognized by state regulators and included in government-backed financing schemes. As the program progresses, it will be important to heed the lessons of previous PPPs in India that were hampered by inadequate financing mechanisms, data and technology, and a misalignment of incentives that kept private provider participation low.
In the months ahead, a new public-private working group has formed to strategize and course correct in India. The group is comprised of representatives from government and non-governmental organizations, civil society and the local and global private sector (including Merck for Mothers). Its initial recommendations include streamlining administrative processes and increasing capacities for collecting, sharing, using and protecting data. In implementing these improvements, India’s new National Health Policy, which advocates in favor of PPPs to help fill critical gaps in care, provides a much-welcomed push from the top.
Enabling public-private partnerships to flourish
There may be practical considerations and internal adjustments to make in order to clear legal and regulatory hurdles and create the enabling environment for PPPs to flourish within particular countries. Certainly, there needs to be greater trust and transparency all around. There is a bounty of technical expertise and tools that can be shared to help countries create PPPs that work for them, within their own unique systems and given their own unique sets of challenges.
There can also be a role for other private sector actors in areas that are outside (yet still connected to) health. Governments can contract with these actors – like those who build roads, provide transport or handle supply chain logistics – to improve health coverage and strengthen overall health systems. For instance, in Senegal, the government has hired local privately held companies for last-mile deliveries of essential medicines, contraceptives and other health products. This is improving efficiencies and solving a critical issue in population health – chronic stock-outs of potentially lifesaving supplies.
Partnering for sustainable progress
There’s a long road ahead to achieve the SDGs. Countries that enlist their local, state and national private sectors as partners in public health will have a better chance at sustainable progress. In the process, many will bring in more private capital to help finance health efforts, create shared value opportunities for global and regional companies, and co-opt private sector innovations for public health service delivery. But in every instance, the private sector role must complement the government’s.
As the World Health Assembly convenes in Geneva this week, I hope to find greater openness toward and increased appetite for PPPs within developing countries. If they’re well-structured arrangements that leverage skills from both sectors and unite them behind a common objective, these partnerships have a unique potential to serve patients and save lives.
Naveen Rao leads Merck for Mothers, an initiative of Merck & Co., Inc.
About Merck for Mothers
Merck for Mothers is a 10-year, 500 million dollar initiative that applies Merck scientific and business expertise – as well as its financial resources and experience in taking on tough global healthcare challenges – to end preventable maternal mortality worldwide. To achieve this, Merck for Mothers is providing transformational and sustainable solutions focused on improving the quality of maternal health care women receive at health facilities and increasing women’s access to family planning.
Merck for Mothers focuses on helping countries reduce maternal mortality and improve maternal health with the overall aim of supporting United Nations’ Sustainable Development Goal (SDG) 3.1, which calls for a global reduction in the maternal mortality ratio to fewer than 70 maternal deaths per 100,000 live births by 2030. For more information, visit www.merckformothers.com.
For more than a century, Merck, a leading global biopharmaceutical company known as MSD outside of the United States and Canada, has been inventing for life, bringing forward medicines and vaccines for many of the world’s most challenging diseases. Through our prescription medicines, vaccines, biologic therapies and animal health products, we work with customers and operate in more than 140 countries to deliver innovative health solutions. We also demonstrate our commitment to increasing access to health care through far-reaching policies, programs and partnerships. Today, Merck continues to be at the forefront of research to advance the prevention and treatment of diseases that threaten people and communities around the world - including cancer, cardio-metabolic diseases, emerging animal diseases, Alzheimer’s disease and infectious diseases including HIV and Ebola. For more information, visit www.merck.com and connect with us on Twitter, Facebook, Instagram, YouTube and LinkedIn.